University of Manchester, Division of Infection, Immunity and Respiratory Medicine


Through the integration of clinical and basic science the Division of Infection, Immunity and Respiratory Medicine of aims to develop, validate and implement novel methodologies for disease diagnosis, monitoring and prediction of outcomes.

Our ultimate objective is to develop novel interventions for patient benefit in our themed areas, including strategies for disease prevention, pharmacological therapies and optimisation of interventions to reduce toxicity and the development of resistance, to allow the customisation of healthcare.

We have world-leading research and development in main themes which is led by international experts:

  1. Chronic Obstructive Pulmonary Disease (COPD)
  2. Chronic cough
  3. Fungal Lung Disease
  4. Asthma and Allergy

The research is based predominantly at the University Hospital of South Manchester (UHSM) with basic science teams based in the Manchester Institute of Biotechnology and the Core Technology Facility on the main University campus.

We feature highly in international rankings, based on our research impact and success, excellence in teaching, and our commitment to social responsibility and engagement. In the REF 2014 assessment, which measures the quality and impact of research across all UK universities, 83% of our research activity was judged to be 'world-leading' (4*) or 'internationally excellent' (3*).

International Experience

The University of Manchester have a proven track record of hosting international researchers. The faculty of Biology, Medicine and Health offers over 90 post-graduate programmes hosting 1300 international students of whom 500 are from the European Union.

Research infrastructure

The respiratory programme of experimental medicine is underpinned by the discovery science of our UoM partners: the Manchester Collaborative Centre for Inflammation Research - a joint AZ/GSK/UoM precompetitive biomedical sciences investment of £15m, the Wellcome Trust Centre for Cell-Matrix Research, Manchester Institute of Biotechnology, the Quantitative Biomedical Imaging Laboratory , the Manchester Fungal Infection Group , the Mycology Reference Centre, eHealth, Computational and Systems Biology, Centre for biological timing in disease.

Trial facilities include a day-case ward, outpatient suite, research physiology laboratories, a state of the art research bronchoscopy suite (opened 2015), and substantially expanded human tissue laboratories for close-to-patient sample processing. The RACRF is co-located within the NWLC, facilitating the seamless transfer of partnership learnings and discoveries into clinical experimental testing. Patients attending the many specialist clinics are offered recruitment to our research tissue bank (n>3500), resulting in a detailed repository of clinical phenotypic information linked to stored biological samples (serum, DNA, PBMC, sputum, biopsies, lung resection material), and also serves as a database for recruitment to future studies.

  • Host center eligibility:

    Global fellowships (return phase only)\ European fellowships

  • Research areas:

    Asthma\ Biomarkers\ COPD\ Cough\ Cystic fibrosis\ Immunology\ Intensive care\ Lung cancer\ Microbiology\ Ventilation

  • Type of research:

    Basic Science\ Clinical Science\ Translational Research

  • Address:

    University Hospital of South Manchester,
    Level 2 ERC,
    Southmoor Road,
    Manchester, M23 9LT, UK

  • Contact person 1:

    Angela Simpson

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Contact person 2:

    Jorgen Vestbo

  • This email address is being protected from spambots. You need JavaScript enabled to view it.